Corcept Therapeutics Inc (CORT)
22.68
-0.32
(-1.39%)
USD |
NASDAQ |
Apr 18, 16:00
22.66
-0.02
(-0.07%)
After-Hours: 20:00
Corcept Therapeutics Accounts Payable (Quarterly): 17.40M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 17.40M |
September 30, 2023 | 16.71M |
June 30, 2023 | 7.976M |
March 31, 2023 | 11.22M |
December 31, 2022 | 11.98M |
September 30, 2022 | 8.178M |
June 30, 2022 | 8.246M |
March 31, 2022 | 9.269M |
December 31, 2021 | 6.908M |
September 30, 2021 | 6.558M |
June 30, 2021 | 9.216M |
March 31, 2021 | 6.969M |
December 31, 2020 | 10.55M |
September 30, 2020 | 6.51M |
June 30, 2020 | 6.304M |
March 31, 2020 | 4.976M |
December 31, 2019 | 7.537M |
September 30, 2019 | 5.937M |
June 30, 2019 | 7.026M |
March 31, 2019 | 9.33M |
December 31, 2018 | 8.266M |
September 30, 2018 | 13.92M |
June 30, 2018 | 6.365M |
March 31, 2018 | 7.85M |
December 31, 2017 | 8.579M |
Date | Value |
---|---|
September 30, 2017 | 6.226M |
June 30, 2017 | 2.082M |
March 31, 2017 | 4.253M |
December 31, 2016 | 2.29M |
September 30, 2016 | 4.309M |
June 30, 2016 | 2.081M |
March 31, 2016 | 2.082M |
December 31, 2015 | 1.325M |
September 30, 2015 | 1.74M |
June 30, 2015 | 2.36M |
March 31, 2015 | 1.036M |
December 31, 2014 | 1.886M |
September 30, 2014 | 1.96M |
June 30, 2014 | 2.595M |
March 31, 2014 | 3.666M |
December 31, 2013 | 2.381M |
September 30, 2013 | 2.337M |
June 30, 2013 | 3.033M |
March 31, 2013 | 2.263M |
December 31, 2012 | 3.804M |
September 30, 2012 | 1.574M |
June 30, 2012 | 4.235M |
March 31, 2012 | 2.084M |
December 31, 2011 | 3.611M |
September 30, 2011 | 1.066M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.976M
Minimum
Mar 2020
17.40M
Maximum
Dec 2023
8.919M
Average
7.976M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
Ultragenyx Pharmaceutical Inc | 42.11M |
Alnylam Pharmaceuticals Inc | 55.52M |
Catalyst Pharmaceuticals Inc | 14.80M |
United Therapeutics Corp | 5.60M |
XOMA Corp | 0.653M |